Stroke progression treatment: blood pressure and antiplatelet therapy
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a combination of blood pressure control and antiplatelet therapy for people whose stroke symptoms are getting worse. It is looking for those without a large brain artery clot or heart-related cause.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke (ischemic type) that started getting worse in the last 7 days.
- Your systolic blood pressure is below 160 and has been stable for over 10 minutes.
- A brain scan shows no large or medium-sized artery blockage.
- You have not had any brain bleeding from this stroke.
- You are not on blood thinners (like warfarin or heparin) for conditions like atrial fibrillation.
- You do not have serious health issues like advanced cancer, kidney failure, or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.
This trial tests whether emergency clot removal (endovascular therapy) can help people whose mild stroke gets worse within a week. It's for those who have a blockage in a large brain artery and enough healthy brain tissue to save.
This trial tests how managing high blood pressure during clot-dissolving treatment for acute ischemic stroke affects recovery. It is for patients who have high blood pressure at the start of treatment.
This trial tests whether keeping blood pressure very tightly controlled after a stroke clot removal (thrombectomy) is better than standard care. It may help people who have had an acute stroke from a large brain artery blockage and still have high blood pressure after the procedure.
This trial tests whether a combination of two or three anti-platelet medicines (like aspirin, clopidogrel, or cilostazol) is safe and works better than one alone for people who had a stroke from a narrowed artery. The goal is to prevent another stroke.
This study tests whether keeping blood pressure at different target levels after emergency clot-removal treatment (called endovascular therapy) can improve recovery from acute ischemic stroke caused by large vessel blockages. The trial will help doctors understand the best blood pressure strategy for patients in the hours right after successful clot removal.
Hear when a new Stroke, Ischemic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.